To this purpose, we first stratified the CML patients according to their BCR-ABL1/ABL1IS transcript value into four groups (Group A, B, C and D) and then we compared Q-PCR measurements obtained from matched samples. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.